Concourse Financial Group Securities, Inc. Apellis Pharmaceuticals, Inc. Transaction History

Concourse Financial Group Securities, Inc.

  • $1.56 Billion
  • Q2 2024

A detailed history of Concourse Financial Group Securities, Inc. transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 1 shares of APLS stock, worth $36. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1
Previous 1 -0.0%
Holding current value
$36
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 25, 2023
BUY
$23.65 - $89.22 $23 - $89
1 New
1 $0
Q2 2023

Aug 10, 2023
BUY
$76.68 - $93.31 $0 - $0
0 New
0 $0
Q1 2023

May 15, 2023
BUY
$46.59 - $66.96 $0 - $0
0 New
0 $0
Q4 2022

Jan 30, 2023
BUY
$43.24 - $61.04 $0 - $0
0 New
0 $0
Q3 2022

Nov 15, 2022
BUY
$44.76 - $69.66 $0 - $0
0 New
0 $0
Q2 2022

Aug 09, 2022
BUY
$35.07 - $59.21 $0 - $0
0 New
0 $0
Q1 2022

May 09, 2022
BUY
$35.46 - $54.12 $0 - $0
0 New
0 $0
Q4 2021

Feb 07, 2022
BUY
$30.74 - $49.16 $0 - $0
0 New
0 $0
Q3 2021

Nov 09, 2021
BUY
$31.4 - $69.84 $0 - $0
0 New
0 $0
Q2 2021

Aug 13, 2021
BUY
$40.9 - $64.9 $0 - $0
0 New
0 $0
Q1 2021

May 13, 2021
BUY
$40.8 - $57.39 $0 - $0
0 New
0 $0
Q4 2020

Feb 02, 2021
BUY
$30.79 - $57.2 $0 - $0
0 New
0 $0
Q3 2020

Nov 13, 2020
BUY
$25.89 - $33.65 $0 - $0
0 New
0 $0
Q2 2020

Aug 13, 2020
BUY
$24.8 - $38.49 $0 - $0
0 New
0 $0
Q1 2020

May 13, 2020
BUY
$17.91 - $44.33 $0 - $0
0 New
0 $0
Q4 2019

Feb 14, 2020
BUY
$22.1 - $30.8 $0 - $0
0 New
0 $0
Q3 2019

Nov 13, 2019
BUY
$24.09 - $32.18 $0 - $0
0 New
0 $0
Q2 2019

Aug 13, 2019
BUY
$18.0 - $25.34 $0 - $0
0 New
0 $0
Q1 2019

May 15, 2019
BUY
$12.81 - $19.82 $0 - $0
0 New
0 $0
Q4 2018

Feb 14, 2019
BUY
$11.47 - $18.71 $0 - $0
0 New
0 $0
Q3 2018

Nov 13, 2018
BUY
$16.57 - $21.03 $0 - $0
0 New
0 $0

Others Institutions Holding APLS

# of Institutions
299
Shares Held
113M
Call Options Held
5.21M
Put Options Held
691K
View Full List

About Apellis Pharmaceuticals, Inc.

APLS Quotes by TradingView
  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $4.04B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email